341 related articles for article (PubMed ID: 20107719)
1. Pruritus in cutaneous T-cell lymphomas: frequent, often severe and difficult to treat.
Meyer N; Paul C; Misery L
Acta Derm Venereol; 2010; 90(1):12-7. PubMed ID: 20107719
[TBL] [Abstract][Full Text] [Related]
2. What's New in Cutaneous T-Cell Lymphoma-Associated Pruritus.
Biazus Soares G; Guitart J; Yosipovitch G
Am J Clin Dermatol; 2024 Jan; 25(1):67-77. PubMed ID: 37971624
[TBL] [Abstract][Full Text] [Related]
3. Mirtazapine and gabapentin for reducing pruritus in cutaneous T-cell lymphoma.
Demierre MF; Taverna J
J Am Acad Dermatol; 2006 Sep; 55(3):543-4. PubMed ID: 16908377
[No Abstract] [Full Text] [Related]
4. Aprepitant improves refractory pruritus in primary cutaneous T-cell lymphomas: experience of the Spanish Working Group on Cutaneous Lymphomas.
Maroñas-Jiménez L; Estrach T; Gallardo F; Pérez A; Andrés Borja H; Servitje O; Pérez Gala S; Linares Barrio M; Jiménez Gallo D; Sanz-Bueno J; Lora D; Monsálvez V; Ortiz-Romero PL
Br J Dermatol; 2018 Apr; 178(4):e273-e274. PubMed ID: 29150837
[No Abstract] [Full Text] [Related]
5. Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphoma.
Whittaker SJ; Foss FM
Cancer Treat Rev; 2007 Apr; 33(2):146-60. PubMed ID: 17275192
[TBL] [Abstract][Full Text] [Related]
6. High-dose recombinant interleukin-2 in advanced cutaneous T-cell lymphoma.
Marolleau JP; Baccard M; Flageul B; Rybojad M; Laroche L; Vérola O; Brandely M; Morel P; Gisselbrecht C
Arch Dermatol; 1995 May; 131(5):574-9. PubMed ID: 7741545
[TBL] [Abstract][Full Text] [Related]
7. Update on treatment of cutaneous T-cell lymphoma.
Gardner JM; Evans KG; Musiek A; Rook AH; Kim EJ
Curr Opin Oncol; 2009 Mar; 21(2):131-7. PubMed ID: 19532014
[TBL] [Abstract][Full Text] [Related]
8. Pruritus in Cutaneous T-Cell Lymphoma and Its Management.
Serrano L; Martinez-Escala ME; Zhou XA; Guitart J
Dermatol Clin; 2018 Jul; 36(3):245-258. PubMed ID: 29929596
[TBL] [Abstract][Full Text] [Related]
9. [Cutaneous lymphoma of the Sézary and Bouvrain type. Progress in physiopathologic and therapeutic outlook].
Bagot M
Bull Acad Natl Med; 1998; 182(5):927-37; discussion 937-8. PubMed ID: 9735499
[TBL] [Abstract][Full Text] [Related]
10. Oral aprepitant in the therapy of refractory pruritus in erythrodermic cutaneous T-cell lymphoma.
Booken N; Heck M; Nicolay JP; Klemke CD; Goerdt S; Utikal J
Br J Dermatol; 2011 Mar; 164(3):665-7. PubMed ID: 21039410
[No Abstract] [Full Text] [Related]
11. Pruritus measurement and treatment.
Langner MD; Maibach HI
Clin Exp Dermatol; 2009 Apr; 34(3):285-8. PubMed ID: 19309370
[TBL] [Abstract][Full Text] [Related]
12. Pruritus in cutaneous T-cell lymphoma: a review.
Ahern K; Gilmore ES; Poligone B
J Am Acad Dermatol; 2012 Oct; 67(4):760-8. PubMed ID: 22285672
[TBL] [Abstract][Full Text] [Related]
13. Aprepitant in the treatment of refractory pruritus secondary to cutaneous T-cell lymphoma.
Borja-Consigliere HA; López-Pestaña A; Vidal-Manceñido MJ; Tuneu-Valls A
Actas Dermosifiliogr; 2014 Sep; 105(7):716-8. PubMed ID: 24139470
[No Abstract] [Full Text] [Related]
14. Memorials and mandates for cutaneous lymphomas.
Heald PW
Arch Dermatol; 2003 Jul; 139(7):926-8. PubMed ID: 12873891
[No Abstract] [Full Text] [Related]
15. [Current therapy concepts in cutaneous T-cell lymphomas].
Nestle FO; Häffner AC; Schmid MH; Dummer R; Burg G
Schweiz Med Wochenschr; 1997 Feb; 127(8):311-20. PubMed ID: 9157537
[TBL] [Abstract][Full Text] [Related]
16. Rational therapy for cutaneous T-cell lymphomas in the 1990s. Fact or fancy?
Bunn PA
Arch Dermatol; 1995 May; 131(5):603-5. PubMed ID: 7537952
[No Abstract] [Full Text] [Related]
17. Treatment of pruritus in early-stage hypopigmented mycosis fungoides with aprepitant.
Jiménez Gallo D; Albarrán Planelles C; Linares Barrios M; Fernández Anguita MJ; Márquez Enríquez J; Rodríguez Mateos ME
Dermatol Ther; 2014; 27(3):178-82. PubMed ID: 24517320
[TBL] [Abstract][Full Text] [Related]
18. An update on mechanisms of pruritus and their potential treatment in primary cutaneous T-cell lymphoma.
Hu M; Scheffel J; Elieh-Ali-Komi D; Maurer M; Hawro T; Metz M
Clin Exp Med; 2023 Dec; 23(8):4177-4197. PubMed ID: 37555911
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous T-cell lymphoma: overview and nursing perspectives.
McCann SA
Nurs Clin North Am; 2007 Sep; 42(3):421-55, vi-vii. PubMed ID: 17825663
[TBL] [Abstract][Full Text] [Related]
20. [Role of aprepitant in the management of pruritus in a patient with cutaneous T-cell lymphoma].
Palacios Zabalza I; López de Torre Querejazu A; Santos Ibañez A
Farm Hosp; 2014 Apr; 38(2):145-7. PubMed ID: 24669900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
